Multi-Component Topical Cream for Severe Diaper Rash

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for diaper rash, including traditional creams and open-air drying, are often insufficient for severe outbreaks and can lead to skin irritation or require trial and error to find an effective solution, while the root cause of diaper rash can be uncertain.

Innovation Solution

A topical cream comprising a mixture of a moisture barrier, steroid, antifungal, and antibiotic components, such as petroleum jelly, hydrocortisone cream, clotrimazole antifungal cream, and triple antibiotic ointment, provides a comprehensive treatment for diaper rash, addressing bacterial and fungal infections and reducing swelling and itching.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional diaper creams containing zinc-oxide are used, then a moisture barrier is provided, but severe diaper rash outbreaks are not effectively treated

Engineering Contradiction:

Improveeffectiveness in treating severe diaper rashVSAvoidability to treat different causes of diaper rash

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines multiple active ingredients (zinc oxide, petroleum jelly, hydrocortisone, clotrimazole, and antibiotics) into a single cream formulation. This merging of different functional components allows the cream to simultaneously provide moisture barrier protection, reduce inflammation, treat fungal infections, and address bacterial infections, thereby effectively treating severe diaper rash outbreaks regardless of their underlying cause.

Inventive Principle:

Principle #5Merging (Combining)

Solution Approach 2:

The diaper cream is designed with multi-functionality to address various causes of diaper rash including moisture-related irritation, fungal infections (candida), and bacterial infections. The universal formulation with multiple active ingredients enables a single product to treat different types of diaper rash presentations, eliminating the need for trial and error with different creams.

Inventive Principle:

Principle #6Universality (Multi-functionality)

2Reliability

If multiple different creams are trialed to find an effective treatment, then the right treatment may be found, but time is lost and skin irritation may occur

Engineering Contradiction:

Improvefinding effective treatmentVSAvoidtime for trial and error

Core Design Contradiction:

ReliabilityVSLoss of time

Solution Approach 1:

The cream formulation includes pre-included active ingredients (hydrocortisone for inflammation, clotrimazole for fungal infections, and antibiotics for bacterial infections) that are ready to address the most common causes of diaper rash from the first application. This preliminary preparation of multiple therapeutic agents eliminates the need for trial and error with different creams, as the comprehensive formulation is designed to work effectively from the start.

Inventive Principle:

Principle #10Preliminary action

3Duration of action of stationary object

If prolonged use of traditional creams is continued, then treatment may be sustained, but further skin irritation or reaction occurs

Engineering Contradiction:

Improveduration of treatmentVSAvoidskin irritation

Core Design Contradiction:

Duration of action of stationary objectVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the parameters of traditional diaper cream formulations by incorporating specific concentrations of hydrocortisone (0.5-2%), clotrimazole (1-2%), and antibiotics (bacitracin zinc, neomycin sulfate, polymyxin B sulfate) that provide sustained therapeutic effect while minimizing irritation. The balanced formulation parameters allow for prolonged use to treat severe outbreaks without causing excessive skin irritation or allergic reactions.

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The cream effectively treats diaper rash quickly and efficiently, regardless of its underlying cause, offering quick resolution and minimizing skin irritation.

Implementation Method 1

the moisture barrier component provides a barrier between affected skin and diaper wetness

Methodology Applied

Scientific EffectPhysical barrier: Physical Containment

Implementation Method 2

the steroid reduces swelling, itching, and/or other discomfort

Methodology Applied

Scientific EffectAnti-inflammatory action:

Implementation Method 3

the antifungal component treats any present fungal skin infection(s)

Methodology Applied

Scientific EffectAntifungal activity:

Implementation Method 4

the antibiotic component treats any present bacterial skin infection(s)

Methodology Applied

Scientific EffectAntibacterial activity:

Data Source

PatentUS20250268978A1Topical cream and method of use

Publication Date: 2025.08.28 WELLSPRING & CO LLC

AI summary

A topical cream composition is provided which comprises a mixture of a moisture barrier component, a steroid component, an antifungal component, and an antibiotic component. The combination of a moisture barrier, a steroid, an antifungal component, and an antibiotic component works together to optimally provide quick treatment and resolution for diaper dermatitis, also known as diaper rash, or other skin condition(s). The moisture barrier component provides a barrier between affected skin and diaper wetness; the steroid reduces swelling, itching, and/or other discomfort; the antifungal component treats any present fungal skin infection(s); and/or the antibiotic component treats any present bacterial skin infection(s). In one aspect, the topical cream comprises a composition of petroleum jelly, hydrocortisone cream, clotrimazole antifungal cream, and triple antibiotic ointment including bacitracin zinc, neomycin sulfate, and polymyxin B sulfate.